All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.
Bookmark this article
The Multiple Myeloma Hub is happy to present a visual abstract summarizing rehabilitation needs associated with CAR T-cell therapies.
There is currently a lack of literature focused on the rehabilitation needs of patients undergoing CAR T-cell therapy; however, rehabilitation strategies can be extrapolated from data on patients who have completed treatment for lymphoma and multiple melanoma and those who receive allogeneic HSCT. Patients frequently present functional and neurological deficits associated with their condition, which are often exasperated by CAR T-cell therapy. These patients can benefit from multifaceted rehabilitation strategies before, during, and after treatment, which can improve their quality of life and treatment outcomes.
To download this visual abstract, click below.Download here
What are the main improvements in next-generation CAR T-cell products?
During the 64th ASH Annual Meeting and Exposition, the Multiple Myeloma Hub was pleased to speak to Benjamin Derman, University of Chicago, Chicago, US. We asked, What are the...
Is experience with ide-cel CAR-T in the real-world setting comparable to the KarMMa trial results?
During the 2022 ASCO Annual Meeting, the Multiple Myeloma Hub was pleased to speak to Doris Hansen, Moffitt Cancer Center, Tampa, US. We asked, Is...
Subscribe to get the best content related to multiple myeloma delivered to your inbox